96 related articles for article (PubMed ID: 37952080)
1. Amplifying Tumor-Stroma Communication: An Emerging Oncogenic Function of Mutant p53.
Capaci V; Mantovani F; Del Sal G
Front Oncol; 2020; 10():614230. PubMed ID: 33505920
[No Abstract] [Full Text] [Related]
2. Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective.
Jill N; Bhootra S; Kannanthodi S; Shanmugam G; Rakshit S; Rajak R; Thakkar V; Sarkar K
Clin Exp Med; 2023 Dec; 23(8):4323-4339. PubMed ID: 37775649
[TBL] [Abstract][Full Text] [Related]
3. Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment.
Dong X; Li C; Deng C; Liu J; Li D; Zhou T; Yang X; Liu Y; Guo Q; Feng Y; Yu Y; Wang Z; Guo W; Zhang S; Cui H; Jiang C; Wang X; Song X; Sun X; Cao L
Oncogene; 2024 Jan; 43(2):92-105. PubMed ID: 37952080
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta.
Madar S; Harel E; Goldstein I; Stein Y; Kogan-Sakin I; Kamer I; Solomon H; Dekel E; Tal P; Goldfinger N; Friedlander G; Rotter V
PLoS One; 2013; 8(4):e61353. PubMed ID: 23630584
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion.
Zhang S; Wang C; Ma B; Xu M; Xu S; Liu J; Tian Y; Fu Y; Luo Y
Cell Rep; 2020 Jul; 32(1):107879. PubMed ID: 32640214
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis.
Cordani M; Pacchiana R; Butera G; D'Orazi G; Scarpa A; Donadelli M
Cancer Lett; 2016 Jul; 376(2):303-9. PubMed ID: 27045472
[TBL] [Abstract][Full Text] [Related]
7. TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress.
Zhu KL; Su F; Yang JR; Xiao RW; Wu RY; Cao MY; Ling XL; Zhang T
Mol Biol Rep; 2024 Jan; 51(1):205. PubMed ID: 38270700
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53
Hernández-Reséndiz I; Gallardo-Pérez JC; López-Macay A; Robledo-Cadena DX; García-Villa E; Gariglio P; Saavedra E; Moreno-Sánchez R; Rodríguez-Enríquez S
J Cell Physiol; 2019 May; 234(5):5524-5536. PubMed ID: 30272821
[TBL] [Abstract][Full Text] [Related]
9. p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression.
Ghosh M; Saha S; Li J; Montrose DC; Martinez LA
Mol Cell; 2023 Jan; 83(2):266-280.e6. PubMed ID: 36638783
[TBL] [Abstract][Full Text] [Related]
10. Clathrin-associated AP-1 controls termination of STING signalling.
Liu Y; Xu P; Rivara S; Liu C; Ricci J; Ren X; Hurley JH; Ablasser A
Nature; 2022 Oct; 610(7933):761-767. PubMed ID: 36261523
[TBL] [Abstract][Full Text] [Related]
11. Gain-of-function p53
Siolas D; Vucic E; Kurz E; Hajdu C; Bar-Sagi D
Cell Rep; 2021 Aug; 36(8):109578. PubMed ID: 34433022
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity.
Zhou X; Singh M; Sanz Santos G; Guerlavais V; Carvajal LA; Aivado M; Zhan Y; Oliveira MMS; Westerberg LS; Annis DA; Johnsen JI; Selivanova G
Cancer Discov; 2021 Dec; 11(12):3090-3105. PubMed ID: 34230007
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
